BioSpace News Archive

Walgreens taking proactive measures in preparation for flu season to meet customer demand and ensure the health and safety of communities during COVID-19 pandemic

Combination of technology, services, and data supports more cost-effective workflows

— GAIN Trial enrollment on track to complete in Q4 2020 — GAIN Trial interim analysis on schedule to complete by year end 2020 — Clinical pipeline expansion anticipated in 2021

HiFiBiO Therapeutics , a multinational biotherapeutics company focused on the development of novel antibodies for immunomodulation, today announced a collaboration with the Coronavirus

Milestone Scientific Inc. (NYSE:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter and six months ending June 30, 2020.

Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that its New Drug Application (NDA) for once-daily, oral relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of women with heavy menstrual bleeding associated with uterine fibroids has been accepted for review by

Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced the appointment of Glen Riley, a global technology industry leader, to its Advisory Board. Mr. Riley joins Resonant’s Advisory Board with over 32 years of successful executive-level experience in the RF, foundry, optical and storage industries. Most recently,

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”) announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar’s stockholders at a special meeting held on August 14 , 2020. The holders of a majority of the outstanding shares of common stock of Adgero have also

CurieAI, a healthcare startup spun-off from SRI Ventures, the corporate venture arm of SRI International, today announced the release of CurieAI’s first-of-its-kind AI-driven platform specifically designed for assisting in the monitoring and management of respiratory conditions surrounding COVID-19.

Theralase® Technologies Inc., a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and associated drug formulations has released the Company Quarterly Newsletter.